{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:30:58Z","timestamp":1791930658710,"version":"4.3.4"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>CD200, a transmembrane type Ia glycoprotein belonging to the immunoglobulin protein superfamily, is broadly expressed on a wide variety of cell types, such as B lymphocytes, a subset of T lymphocytes, dendritic cells, endothelial and neuronal cells. It delivers immunosuppressive signals through its receptor CD200R, which is expressed on monocytes\/myeloid cells and T lymphocytes. Moreover, interaction of CD200 with CD200R has also been reported to play a role in the regulation of tumor immunity. Overexpression of CD200 has been reported in chronic lymphocytic leukemia (CLL) and hairy cell leukemia but not in mantle cell lymphoma, thus helping to better discriminate between these different B cell malignancies with different prognosis. In this review, we focus on the role of CD200 expression in the differential diagnosis of mature B-cell neoplasms and on the prognostic significance of CD200 expression in CLL, where conflicting results have been published so far. Of interest, increasing evidences indicate that anti-CD200 treatment might be therapeutically beneficial for treating CD200-expressing malignancies, such as CLL.<\/jats:p>","DOI":"10.3389\/fonc.2020.584427","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T15:18:01Z","timestamp":1606403881000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance"],"prefix":"10.3389","volume":"10","author":[{"given":"Giovanni","family":"D\u2019Arena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"De Feo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pietrantuono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Seneca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Mansueto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oreste","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"La Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorella","family":"D\u2019Auria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodora","family":"Statuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Valvano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Arruga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Deaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitar G.","family":"Efremov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sgambato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Laurenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00364281","article-title":"The gene for MRC OX-2 membrane glycoprotein is localised on human chromosome 3","volume":"25","author":"McCaughan","year":"1987","journal-title":"Immunogenetics"},{"key":"B2","article-title":"CD200 (CD200 molecule). Atlas Genet. Cytogenet","volume":"13","author":"Mathews","year":"2009","journal-title":"Oncol Hematol"},{"key":"B3","article-title":"Neuronal\/lymphoid membrane glycoprotein MRC OX-2 is a member of the immunoglobulin superfamily with a light-chain-like structure","volume":"51","author":"Barclay","year":"1986","journal-title":"Biochem Soc Symp"},{"key":"B4","doi-asserted-by":"publisher","first-page":"9067","DOI":"10.1093\/nar\/16.18.9067","article-title":"2RFLP and mapping of human MOX-1 gene on chromosome 3","volume":"16","author":"Douglas","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.6.3034","article-title":"Lymphoid\/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function","volume":"13","author":"Wright","year":"2000","journal-title":"Immunity"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1046\/j1365-2567.2001.01163.x","article-title":"The unusual distribution of the neuronal\/lymphoid cell surface C200 (OX2) glycoprotein is conserved in humans","volume":"102","author":"Wright","year":"2001","journal-title":"Immunology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.6.3034","article-title":"Characterization of the CD200 receptor family in mice and humans and their interactions with CD200","volume":"171","author":"Wright","year":"2003","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2008.07.005","article-title":"Cancer stem Cells, CD200 and immunoevasion","volume":"29","author":"Kawasaki","year":"2008","journal-title":"Trends Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.9.5946","article-title":"An interaction between CD200 and monoclonal antibody agonists to CD200R2 in development of dendritic cells that preferentially induce populations of CD4+CD25+ T regulatory cells","volume":"180","author":"Gorczynski","year":"2008","journal-title":"J Immunol"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1097\/01.TP.0000152118.51622.F9","article-title":"Augmented induction of CD4+CD25+ Treg using monoclonal antibodies to CD200R","volume":"79","author":"Gorczynski","year":"2005","journal-title":"Transplantation"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.11.6786","article-title":"Molecular mechanisms of CD200 inhibition of mast cell activation","volume":"173","author":"Zhang","year":"2004","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.3.1348","article-title":"The CD200 receptor is a novel and potent regulator of murine and human mast cell function","volume":"174","author":"Cherwinski","year":"2005","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.7.4441","article-title":"Down-regulation of basophil function by human CD200 and human herpesvirus-8 CD200","volume":"175","author":"Shiratori","year":"2005","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.1","article-title":"CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia","volume":"25","author":"Coles","year":"2011","journal-title":"Leukemia"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/science.290.5497.1768","article-title":"Down-regulation of the macrophage lineage through interaction with OX2 (CD200)","volume":"290","author":"Hoek","year":"2000","journal-title":"Science"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.162.2.774","article-title":"Evidence that an OX2-positive cell can inhibit the stimulation of type1 cytokine production by bone marrow-derived B7-1 (and B7-2)-positive dendritic cells","volume":"162","author":"Gorczynski","year":"1999","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200108)31:8<2331::aid-immu2331>3.0.c0:2-#","article-title":"Transplant tolerance modifying antibody to CD200 receptor, but not CD200, alters cytokine production profile from stimulated macrophages","volume":"31","author":"Gorczynski","year":"2001","journal-title":"Eur J Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0510081103","article-title":"Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation","volume":"103","author":"McWhirter","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.11.103","article-title":"CD200: a putative theraputic target in cancer","volume":"366","author":"Moreaux","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.118\/blood-2006-06-029355","article-title":"CD200 is a new prognostic factor in multiple myeloma","volume":"108","author":"Moreaux","year":"2006","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404559","article-title":"CD200 as a prognostic factor in acute myeloid leukaemia","volume":"21","author":"Tonks","year":"2007","journal-title":"Leukemia"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.9.5595","article-title":"CD200 expression on tumor cells suppresses antitumor immunity: new approaches to cancer immunotherapy","volume":"178","author":"Kretz-Rommel","year":"2007","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1517\/14712598.8.1.5","article-title":"Rationale for anti-CD200 immunotherapy in B-CLL and other hematologic malignancies: new concepts in blocking immune suppression","volume":"8","author":"Kretz-Rommel","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"B24","doi-asserted-by":"publisher","first-page":"699","DOI":"10.4049\/jimmunol.180.2.699","article-title":"Blockade of CD200 in the presence or absence of antibody effector function: implications for anti-CD200 therapy","volume":"180","author":"Kretz-Rommel","year":"2008","journal-title":"J Immunol"},{"key":"B25","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","volume-title":"World Health Organization Classification of Tumours","author":"Swerdlow","year":"2008"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3109\/1042819000914884","article-title":"Chronic lymphoproliferative disorders: an integrated point of view for the differential diagnosis","volume":"36","author":"D\u2019Arena","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"B28","article-title":"The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL","volume":"8","author":"Matutes","year":"1994","journal-title":"Leukemia"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/108.4.378","article-title":"Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b)","volume":"108","author":"Moreau","year":"1997","journal-title":"Am J Clin Pathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07644.x","article-title":"CD200\/OX2, a cell surface molecule with immuno-regulatory function is consistently expressed on hairy cell leukaemia neoplastic cells","volume":"145","author":"Brunetti","year":"2009","journal-title":"Br J Haematol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukeres.2009.01.017","article-title":"CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia","volume":"33","author":"Palumbo","year":"2009","journal-title":"Leuk Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP38XRRUGSQOVc","article-title":"CD200 (OX-2 membrane glycoprotein) expression in B cell-derived neoplasms","volume":"134","author":"Dorfman","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1182\/blood.V116.21.1673.1673","article-title":"The utility of CD200 expression in the differentiation on mantle cell lymphoma and B-cell chronic lymphocytic leukemia: a single centre experience","volume":"116","author":"Bhatnagar","year":"2010","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2310\/JIM.0b13e31823908fb","article-title":"CD200 expression in B-cell chronic lymphoproliferatve disorders","volume":"60","author":"El Desoukey","year":"2012","journal-title":"J Invest Med"},{"key":"B35","first-page":"329","article-title":"Utility of CD200 in the diagnosis of chronic lymphocytic leukemia","author":"Cherian","year":"2012","journal-title":"Cytometry Part B- Clin Cytom"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1182\/blood.V120.21.2660.2660","article-title":"Diagnostic value of CD200 expression for the differentiation between chronic lymphocytic leukemia (CLL), CLL with increased prolymphocytes (CLL\/PL) and mantle cell lymphoma","volume":"120","author":"Kern","year":"2012","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1309\/AJCP59UORCYZEVQO","article-title":"Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma","volume":"137","author":"Alapat","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPEBK31VQQNDDR","article-title":"CD200 flow cytometric assessment and semiquantitative immunohistochemical staining distinguishes hairy cell leukemia from hairy cell leukemia-variant and other B-cell lymphoproliferative disorders","volume":"140","author":"Pillai","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"B39","first-page":"406","article-title":"CD200 expression in B-chronic lymphocytic leukemia \u2013 it is not an all or none phenomenon","volume":"84","author":"Dasgupta","year":"2013","journal-title":"Cytometry Part B- Clin Cytom"},{"key":"B40","article-title":"Flow cytometric evaluation of CD200 as a tool for differentiation between chronic lymphocytic leukemia and mantle cell lymphoma","volume":"39","author":"El-Sewefy","year":"2014","journal-title":"Egyptian J Haematol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/cyto.b.21128","article-title":"CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multioparameter flow cytometry","volume":"86","author":"Sandes","year":"2014","journal-title":"Cytometry B Clin Citom"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPBV9ELXCOECVL","article-title":"Differential expression of CD200 in B-cell neoplasms by flow cytometry can assist in diagnosis, subclassification, and bone marrow staging","volume":"142","author":"Challagundla","year":"2014","journal-title":"Amer J Clin Pathol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1182\/blood.V124.21.5637.5637","article-title":"CD200 expression improves differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma","volume":"124","author":"Karban","year":"2014","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP02KKFMOEXNZF","article-title":"CD200 in high-grade lymphoma, chronic lymphocytic leukemia, and chronic lymphocytic leukemia-phenotype monoclonal B-cell lymphocytosis","volume":"144","author":"Sorigue","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12315","article-title":"Combination of CD160 and CD200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B-cell neoplasms","volume":"37","author":"Lesesve","year":"2015","journal-title":"Int J Lab Hematol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1030642","article-title":"Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoprolifeartive disorders and their potential value in differential diagnosis","volume":"56","author":"Fan","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"B47","doi-asserted-by":"publisher","first-page":"5278","DOI":"10.1182\/blood.V126.23.5278.5278","article-title":"Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders","volume":"126","author":"Naseem","year":"2015","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4103\/0974-1482.188432","article-title":"Atypical presentation of hairy cell leukemia: significance of CD200 on flow cytometry","volume":"14","author":"Rahman","year":"2018","journal-title":"J Canc Res Ther"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.111\/ijlh.12637","article-title":"Role of CD200 in differential diagnosis of mature B-cell neoplasms","volume":"39","author":"Rahman","year":"2017","journal-title":"Int J Lab Hematol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12857","article-title":"CD200 is a useful diagnostic marker for identifying atypical chronic lymhocytic leukemia by flow cytometry","volume":"40","author":"Ting","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjhh-2017.05.002","article-title":"Quantitative flow cytometric evaluation of CD200, CD123, CD43 and CD52 as a tool for the differential diagnosis of mature B-cell neoplasms","volume":"39","author":"Arlindo","year":"2017","journal-title":"Rev Bras Hematol Hemother"},{"key":"B52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/AJCP\/AQX041","article-title":"Flow cytometric patterns of CD200 and cD1d expression distinguish CD10-negative, CD5-negative mature B-cell lymphoproliferative disorders","volume":"148","author":"Mason","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21607","article-title":"Quantitative assessment of informative immunophenotypic markers increases the diagostic value of immunophenotyping in mature CD5-positive B-cell neoplasms","author":"Starostka","year":"2017","journal-title":"Cytometry Part B \u2013 Clin Cytometry"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2461","article-title":"Spectum and immunophenotyping of 653 patients with B-cell chronic lymphoproliferative disorders in China: a single-centre analysis","volume":"36","author":"Miao","year":"2018","journal-title":"Hematol Oncol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4103\/IJPM.IJPM_267_17","article-title":"Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders","volume":"61","author":"Poongodi","year":"2018","journal-title":"Indian J Pathol Microb"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12824","article-title":"Usefulness of CD200 in the differential diagnosis of SDRPL, SMZL, and HCL","volume":"40","author":"Favre","year":"2018","journal-title":"Int J Lab Hem"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4274\/tih.2017.0085","article-title":"The role of CD200 and CD43 expression in differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma","volume":"35","author":"Falay","year":"2018","journal-title":"Turk J Hematol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2510","article-title":"CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia","volume":"36","author":"D\u2019Arena","year":"2018","journal-title":"Hematol Oncol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/hon.2511","article-title":"CD200 expression in flow cytometry helps to distinguish mantle cell lymphoma from other CD5-positive B-cell neoplasms","volume":"36","author":"Debord","year":"2018","journal-title":"Hematol Oncol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.217222","article-title":"CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia","volume":"96","author":"Mora","year":"2019","journal-title":"Cytometry B Clin Cytom"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10428194.2019.1663420","article-title":"The utility of CD200 expression and modified Matutes score in the diagnostic differentiation of mantle cell lymhoma and chronic lymphocytic leukemia using flow cytometry","volume":"27","author":"Myles","year":"2019","journal-title":"Leuk Lymphoma Sep"},{"key":"B62","first-page":"87","article-title":"Evaluation of the diagnostic usefulness of CD200 marker in chronic lymphocytic leukaemia and mature B-cell lymphoproliferative disorders","volume":"185","author":"Soong","year":"2019","journal-title":"Br J Haematol 2019"},{"key":"B63","first-page":"27","article-title":"Evaluation of CD160 and CD200 expression as differentiating markers between chronic lymphocytic leukemia and other mature B-cell neoplasms","volume":"14","author":"El-Neanaey","year":"2020","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"B64","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.161.6.2780","article-title":"Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes","volume":"161","author":"Anumanthan","year":"1998","journal-title":"J Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-239483","article-title":"CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia","volume":"115","author":"Liu","year":"2010","journal-title":"Blood"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14901","article-title":"Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200","volume":"179","author":"Khonke","year":"2017","journal-title":"Br J Haematol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21623","article-title":"Usefulness of the CLLflow score","volume":"94","author":"Sorigue","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1136\/jim-2018-000832","article-title":"External validation of the accuracy of \u2018CLLflow score\u2019","volume":"66","author":"D\u2019Arena","year":"2018","journal-title":"J Investig Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21509","article-title":"Expression of CD43 in chronic lymphoproliferative leukemias","volume":"94","author":"Sorigue","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21760","article-title":"Refining the limits of borderline lymphoproliferative disorders","volume":"96","author":"Sorigue","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21849","article-title":"Positive predictive value of CD200 positivity in the differential diagnosis of chronic lymphocytic leukemia","volume":"98","author":"Sorigue","year":"2019","journal-title":"Cytometry"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20534","article-title":"Chronic lymphocytic leukemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing","author":"Rawstron","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"key":"B73","article-title":"Expression of CD200 in the bone marrow of chronic lymphocytic leukemia patients and its correlations with clinical prognosis","volume":"30","author":"Wang","year":"2014","journal-title":"Chin J Cell Mol Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2018.19.12.338","article-title":"CD200 expression in diagnostic and prognostic assessment of mature B cell lymphoproliferative neoplasms","volume":"19","author":"El Din Fouad","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6948","article-title":"Low expression of CD200 predicts shorter time-to treatment in chronic lymphocytic leukemia","volume":"7","author":"Miao","year":"2016","journal-title":"Oncotarget"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2019.106169","article-title":"CD200 and prognosis in chronic lymphocytic leukemia: conflicting results","volume":"83","author":"D\u2019Arena","year":"2019","journal-title":"Leuk Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41698-018-0061-2","article-title":"A platform for phenotypic discovery of therapeutic antibodies and targets applied on chronic lymphocytic leukemia","volume":"2","author":"Ljungars","year":"2018","journal-title":"Precis Oncol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-013-2735-3","article-title":"Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling","volume":"142","author":"Gorczynski","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152073","article-title":"Characterization of CD200 ectodomain shedding","volume":"11","author":"Wong","year":"2016","journal-title":"PloS One 2016;"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-019-0710-1","article-title":"Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200","volume":"227","author":"Mahadevan","year":"2019","journal-title":"J ImmunoTher Canc 7"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-1390","article-title":"Soluble CD200 is critical to engraft chronic lymphocytic leukemia cells in immunocompromised mice","volume":"72","author":"Wong","year":"2012","journal-title":"Cancer Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.04.014","article-title":"Ectodomain shedding of CD200 from the B-CLL surface is regulated by ADAM28 expression","volume":"37","author":"Twito","year":"2013","journal-title":"Leuk Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-412510","article-title":"Coinhibitory molecules in hematologic malignancies: targets for therapeutic intervention","volume":"120","author":"Norde","year":"2012","journal-title":"Blood"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3109\/07357907.2012.756110","article-title":"Increased frequency of CD8+ and CD4+ regulatory T cells in chronic lymphocytic leukemia: association with disease progression","volume":"31","author":"Jadidi-Niaragh","year":"2013","journal-title":"Cancer Invest"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.584427\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T01:38:04Z","timestamp":1697247484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.584427\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":84,"alternative-id":["10.3389\/fonc.2020.584427"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.584427","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,26]]},"article-number":"584427"}}